Home
Scholarly Works
CCTG EN10: A phase II study of tailored adjuvant...
Conference

CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)-RAINBO BLUE and TAPER

Authors

McAlpine JN; Han KC-Z; Kinloch M; Barkati M; Ferguson SE; Fyles AW; Huang F; Kong I; Kwon JS; Mackay H

Volume

41

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2023

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

IL, Chicago

Conference start date

June 2, 2023

Conference end date

June 6, 2023

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team